Role of IL-10 in the distribution of B cell subsets in the mouse B-1 cell population

European Cytokine Network

Volumn 14, Issue 3, 2003, Pages 178-185

  Pers, Jacques Olivier ^a   Jamin, Christophe ^a   Youinou, Pierre ^a   Charreire, Jeannine ^b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Lymphocyte; Peritoneal cells; Self renewal

Indexed keywords

CD5 ANTIGEN; INTERLEUKIN 10; PROTEIN BAD; PROTEIN BAX;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; INTERLEUKIN-10; MICE; MICE, INBRED CBA; MICE, KNOCKOUT; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA;

EID: 0141922966     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Youinou P, Jamin C, Lydyard PM. 1999. CD5 expression in human B-cell populations. (Review) Immunol. Today 20: 312.
2. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. 1983. The «Ly-1 B» cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202.
3. Pers JO, Jamin C, Lydyard PM, Charreire J, Youinou P. 2002. The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics 54: 208.
4. Stall AM, Adams S, Herzenberg LA, Kantor AB. 1992. Characteristics and development of the murine B-1b (Ly-1 sister) cell population. (Review) Ann. NY Acad. Sci. 651: 33.
5. Wortis HH, Berland R. 2001. Cutting edge commentary: origins of B-1 cells. (Review) J. Immunol. 166: 2163.
6. Herzenberg LA. 2000. B-1 cells: the lineage question revisited. (Review) Immunol. Rev. 175: 9.
7. Huang CA, Henry C, Iacomini J, Imanishi-Kari T, Wortis HH. 1996. Adult bone marrow contains precursors for CD5+ B cells. Eur. J. Immunol. 26: 2537.
8. Kantor AB, Stall AM, Adams S, Herzenberg LA, Herzenberg LA. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl Acad. Sci. USA 89: 3320.
9. Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161: 1554.
10. Lalor PA, Stall AM, Adams S, Herzenberg LA. 1989. Permanent alteration of the murine Ly-1 B repertoire due to selective depletion of Ly-1 B cells in neonatal animals. Eur. J. Immunol. 19: 501.
11. Foussat A, Balabanian K, Amara A, Bouchet-Delbos L, Durand-Gasselin I, Baleux F, Couderc J, Galanaud P, Emilie D. 2001. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur. J. Immunol. 31: 350.
12. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711.
13. Ishida H, Hastings R, Kearney J, Howard M. 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175: 1213.
14. Peng B, Mehta NH, Fernandes H, Chou CC, Raveche E. 1995. Growth inhibition of malignant CD5+ B (B-1) cells by antisense IL-10 oligonucleotide. Leuk. Res. 19: 159.
15. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, et al. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181: 839.
16. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH. 1992. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133: 275.
17. Tominaga A, Takaki S, Koyama N, Katoh S, Matsumoto R, Migita M, Hitoshi Y, Hosoya Y, Yamauchi S, Kanai Y, et al. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173: 429.
18. Vink A, Warnier G, Brombacher F, Renauld JC. 1999. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J. Exp. Med. 189: 1413.
19. Fine JS, Macosko HD, Grace MJ, Narula SK. 1994. Influence of IL-10 on murine CFU-pre-B formation. Exp. Hematol. 22: 1188.
20. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263.
21. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM. 1996. T helper cell 1-type CD4 + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184: 241.
22. Deenen GJ, Kroese FG. 1993. Kinetics of peritoneal B-1a cells (CD5 B cells) in young adult mice. Eur. J. Immunol. 23: 12.
23. Wardemann H, Boehm T, Dear N, Carsetti R. 2002. B-1a B cells that link the innate and adaptative immune responses are lacking in the absence of the spleen. J. Exp. Med. 195: 771.
24. Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. 1995. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl Acad. Sci. USA 92: 3348.
25. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185: 1035.
26. Fan H, Rothstein TL. 2001. Lymphokine dependence of STAT3 activation produced by surface immunoglobulin cross-linking and by phorbol ester plus calcium ionophore treatment in B cells. Eur. J. Immunol. 31: 665.
27. Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, Amara A, Baleux F, Portier A, Galanaud P, Emilie D. 2002. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 99: 427.
28. Merville P, Dechanet J, Grouard G, Durand I, Banchereau J. 1995. T cell-induced B cell blasts differentiate into plasma cells when cultured on bone marrow stroma with IL-3 and IL-10. Int. Immunol. 7: 635.
29. Elia JM, Hamilton BL, Riley RL. 1995. IL-10 inhibits IL-7-mediated murine pre-B cell growth in vitro. Exp. Hematol. 23: 323.
30. . Grohmann U, Van Snick J, Campanile' F, Silla S, Giampietri A, Vacca C, Renauld JC, Fioretti MC, Puccetti P. 2000. IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J. Immunol. 164: 4197.